V E Kelly1, C O Johnson2, E L McGough3, A Shumway-Cook4, F B Horak5, K A Chung6, A J Espay7, F J Revilla8, J Devoto9, C Wood-Siverio10, S A Factor11, B Cholerton12, K L Edwards13, A L Peterson14, J F Quinn15, T J Montine16, C P Zabetian17, J B Leverenz18. 1. Department of Rehabilitation Medicine, University of Washington, Seattle, WA, United States. Electronic address: vekelly@u.washington.edu. 2. Department of Epidemiology, University of Washington, Seattle, WA, United States. Electronic address: johnsoco@uw.edu. 3. Department of Rehabilitation Medicine, University of Washington, Seattle, WA, United States. Electronic address: emcg@uw.edu. 4. Department of Rehabilitation Medicine, University of Washington, Seattle, WA, United States. Electronic address: ashumway@uw.edu. 5. Department of Neurology, Oregon Health and Science University, Portland, OR, United States; Portland Veterans Affairs Medical Center, Portland, OR, United States. Electronic address: horakf@ohsu.edu. 6. Department of Neurology, Oregon Health and Science University, Portland, OR, United States; Portland Veterans Affairs Medical Center, Portland, OR, United States. Electronic address: chungka@ohsu.edu. 7. Department of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, OH, United States. Electronic address: alberto.espay@uc.edu. 8. Department of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, OH, United States; Division of Neurology, Greenville Health System and University of South Carolina Medical School-Greenville, United States. Electronic address: fredy.revilla@uc.edu. 9. Department of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, OH, United States. Electronic address: devotoj@ucmail.uc.edu. 10. Department of Neurology, Emory University, Atlanta, GA, United States. Electronic address: cwoodsi@emory.edu. 11. Department of Neurology, Emory University, Atlanta, GA, United States. Electronic address: sfactor@emory.edu. 12. Geriatric Research, Education, and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, United States; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States. Electronic address: bchol@uw.edu. 13. Department of Epidemiology, University of Washington, Seattle, WA, United States; Department of Epidemiology, University of California, Irvine, CA, United States. Electronic address: kedward1@uci.edu. 14. Department of Neurology, Oregon Health and Science University, Portland, OR, United States; Portland Veterans Affairs Medical Center, Portland, OR, United States. Electronic address: peterami@ohsu.edu. 15. Department of Neurology, Oregon Health and Science University, Portland, OR, United States; Portland Veterans Affairs Medical Center, Portland, OR, United States. Electronic address: quinnj@ohsu.edu. 16. Department of Pathology, University of Washington, Seattle, WA, United States. Electronic address: tmontine@uw.edu. 17. Geriatric Research, Education, and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, United States; Parkinson's Disease Research, Education, and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, United States; Department of Neurology, University of Washington, Seattle, WA, United States. Electronic address: zabetian@u.washington.edu. 18. Lou Ruvo Center for Brain Health, Cleveland Clinic, Cleveland, OH, United States. Electronic address: leverej@ccf.org.
Abstract
INTRODUCTION: Research suggests an association between global cognition and postural instability/gait disturbance (PIGD) in Parkinson disease (PD), but the relationship between specific cognitive domains and PIGD symptoms is not clear. This study examined the association of cognition (global and specific cognitive domains) with PIGD symptoms in a large, well-characterized sample of individuals with PD. METHODS: Cognitive function was measured with a detailed neuropsychological assessment, including global cognition, executive function, memory, visuospatial function, and language. PIGD symptoms were measured using the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III, Motor Examination subscale. Multiple linear regression analyses were performed to assess the relationship between cognition and PIGD symptoms with models adjusting for age, sex, education, enrollment site, disease duration, and motor symptom severity. RESULTS: The analysis included 783 participants, with mean (standard deviation) age of 67.3 (9.7) years and median (interquartile range) MDS-UPDRS Motor Subscale score of 26 (17, 35). Deficits in global cognition, executive function, memory, and phonemic fluency were associated with more severe PIGD symptoms. Deficits in executive function were associated with impairments in gait, freezing, and postural stability, while visuospatial impairments were associated only with more severe freezing, and poorer memory function was associated only with greater postural instability. DISCUSSION: While impairments in global cognition and aspects of executive functioning were associated with more severe PIGD symptoms, specific cognitive domains were differentially related to distinct PIGD components, suggesting the presence of multiple neural pathways contributing to associations between cognition and PIGD symptoms in persons with PD.
INTRODUCTION: Research suggests an association between global cognition and postural instability/gait disturbance (PIGD) in Parkinson disease (PD), but the relationship between specific cognitive domains and PIGD symptoms is not clear. This study examined the association of cognition (global and specific cognitive domains) with PIGD symptoms in a large, well-characterized sample of individuals with PD. METHODS: Cognitive function was measured with a detailed neuropsychological assessment, including global cognition, executive function, memory, visuospatial function, and language. PIGD symptoms were measured using the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III, Motor Examination subscale. Multiple linear regression analyses were performed to assess the relationship between cognition and PIGD symptoms with models adjusting for age, sex, education, enrollment site, disease duration, and motor symptom severity. RESULTS: The analysis included 783 participants, with mean (standard deviation) age of 67.3 (9.7) years and median (interquartile range) MDS-UPDRS Motor Subscale score of 26 (17, 35). Deficits in global cognition, executive function, memory, and phonemic fluency were associated with more severe PIGD symptoms. Deficits in executive function were associated with impairments in gait, freezing, and postural stability, while visuospatial impairments were associated only with more severe freezing, and poorer memory function was associated only with greater postural instability. DISCUSSION: While impairments in global cognition and aspects of executive functioning were associated with more severe PIGD symptoms, specific cognitive domains were differentially related to distinct PIGD components, suggesting the presence of multiple neural pathways contributing to associations between cognition and PIGD symptoms in persons with PD.
Authors: Irene Litvan; Jennifer G Goldman; Alexander I Tröster; Ben A Schmand; Daniel Weintraub; Ronald C Petersen; Brit Mollenhauer; Charles H Adler; Karen Marder; Caroline H Williams-Gray; Dag Aarsland; Jaime Kulisevsky; Maria C Rodriguez-Oroz; David J Burn; Roger A Barker; Murat Emre Journal: Mov Disord Date: 2012-01-24 Impact factor: 10.338
Authors: G Stennis Watson; Brenna A Cholerton; Rachel G Gross; Daniel Weintraub; Cyrus P Zabetian; John Q Trojanowski; Thomas J Montine; Andrew Siderowf; James B Leverenz Journal: Alzheimers Dement Date: 2012-11-16 Impact factor: 21.566
Authors: Nicolaas I Bohnen; Kirk A Frey; Stephanie Studenski; Vikas Kotagal; Robert A Koeppe; Peter J H Scott; Roger L Albin; Martijn L T M Müller Journal: Neurology Date: 2013-09-27 Impact factor: 9.910
Authors: J Green; W M McDonald; J L Vitek; M Evatt; A Freeman; M Haber; R A E Bakay; S Triche; B Sirockman; M R DeLong Journal: Neurology Date: 2002-11-12 Impact factor: 9.910
Authors: David J Irwin; Matthew T White; Jon B Toledo; Sharon X Xie; John L Robinson; Vivianna Van Deerlin; Virginia M-Y Lee; James B Leverenz; Thomas J Montine; John E Duda; Howard I Hurtig; John Q Trojanowski Journal: Ann Neurol Date: 2012-10-04 Impact factor: 10.422
Authors: Brenna A Cholerton; Cyrus P Zabetian; Joseph F Quinn; Kathryn A Chung; Amie Peterson; Alberto J Espay; Fredy J Revilla; Johnna Devoto; G Stennis Watson; Shu-Ching Hu; Karen L Edwards; Thomas J Montine; James B Leverenz Journal: J Parkinsons Dis Date: 2013 Impact factor: 5.568
Authors: Christopher G Goetz; Barbara C Tilley; Stephanie R Shaftman; Glenn T Stebbins; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Matthew B Stern; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J van Hilten; Nancy LaPelle Journal: Mov Disord Date: 2008-11-15 Impact factor: 10.338
Authors: Krista Specketer; Cyrus P Zabetian; Karen L Edwards; Lu Tian; Joseph F Quinn; Amie L Peterson-Hiller; Kathryn A Chung; Shu-Ching Hu; Thomas J Montine; Brenna A Cholerton Journal: J Clin Exp Neuropsychol Date: 2019-06-10 Impact factor: 2.475
Authors: Tyler Harrison Reekes; Christopher Ian Higginson; Christina Raye Ledbetter; Niroshan Sathivadivel; Richard Matthew Zweig; Elizabeth Ann Disbrow Journal: NPJ Parkinsons Dis Date: 2020-04-08
Authors: Nicole Licking; Charles Murchison; Brenna Cholerton; Cyrus P Zabetian; Shu-Ching Hu; Thomas J Montine; Amie L Peterson-Hiller; Kathryn A Chung; Karen Edwards; James B Leverenz; Joseph F Quinn Journal: Parkinsonism Relat Disord Date: 2017-08-09 Impact factor: 4.891
Authors: Ana Claudia de Souza Fortaleza; Martina Mancini; Patty Carlson-Kuhta; Laurie A King; John G Nutt; Eliane Ferrari Chagas; Ismael Forte Freitas; Fay B Horak Journal: Gait Posture Date: 2017-05-10 Impact factor: 2.840
Authors: A Perrochon; R Holtzer; M Laidet; S Armand; F Assal; P H Lalive; G Allali Journal: J Neural Transm (Vienna) Date: 2016-12-22 Impact factor: 3.575